DCGO — DocGo Inc.

Summary of DocGo Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Total Revenue: $70.8 million, down from $138.7 million in Q3 2024, primarily due to the end of migrant-related projects. Excluding these, revenue increased by 8% to $62.4 million.
• Medical Transportation Revenue: Increased to $50.1 million from $48 million in 2024.
• Mobile Health Revenue: Decreased to $20.7 million from $90.7 million, impacted by the wind-down of migrant services; non-migrant mobile health revenues grew by over 20%.
• Adjusted EBITDA: Loss of $7.1 million compared to a profit of $17.9 million in Q3 2024. Adjusted gross margin was 33%, down from 36% in 2024.
• Balance Sheet: Cash and cash equivalents were $95.2 million, down from $170.1 million at the start of the year, but the company is now debt-free after paying off its credit line.

2. Strategic Updates and Business Highlights

• Record Volumes: Achieved across all base business offerings, indicating strong demand.
• Acquisition of SteadyMD: Completed in October, expected to enhance virtual care capabilities with a 50-state network and over 500 providers, contributing approximately $25 million in revenue for 2026.
• Medical Transportation: Anticipated to generate over $200 million in revenue for 2025, with plans to improve EBITDA margins to approximately 12% through scaling and staffing.
• Payer and Provider Vertical: Expected to grow from $50 million in 2025 to $85 million in 2026, with significant contributions from SteadyMD and organic growth.

3. Forward Guidance and Outlook

• 2025 Revenue Guidance: Expected to be between $315 million and $320 million, with base revenue around $250 million after excluding migrant projects.
• 2026 Revenue Guidance: Projected between $280 million and $300 million, representing 12% to 20% growth over base revenues. Adjusted EBITDA loss expected to range from $15 million to $25 million, with a potential positive EBITDA run rate by year-end.

4. Bad News, Challenges, or Points of Concern

• Revenue Decline: Significant drop in total revenue due to the cessation of migrant-related contracts, impacting overall financial performance.
• Adjusted EBITDA Loss: Continued losses raise concerns about profitability, particularly with substantial investments in new business lines.
• Market Sentiment: Potential caution among hospital executives regarding spending due to uncertainty in healthcare policies and reimbursement levels.
• Operational Challenges: The need for significant hiring in the medical transportation segment to meet demand, which could strain resources if not managed effectively.

5. Notable Q&A Insights

• Margin Projections: Expected negative EBITDA margins in Q4 2025 and throughout the first half of 2026, with improvements anticipated in the latter half of the year.
• Pipeline Growth: Strong growth in the payer/provider vertical is based on existing contracts, with no new revenue from migrant services expected in 2026.
• Market Dynamics: The focus on cardiology for remote patient monitoring aligns with market trends, especially as some insurers limit RPM coverage, potentially benefiting DocGo's offerings.
• Customer Sentiment: Hospital systems are increasingly receptive to outsourcing patient flow management, presenting new opportunities for DocGo.

This summary encapsulates the key points from DocGo's Q3 2025 earnings call, highlighting both the positive developments and the challenges the company faces moving forward.